Rhinopithecus roxellana (golden snub-nosed monkey): 104673141
Help
Entry
104673141 CDS
T03989
Symbol
BAD
Name
(RefSeq) bcl2-associated agonist of cell death
KO
K02158
Bcl-2-antagonist of cell death
Organism
rro
Rhinopithecus roxellana (golden snub-nosed monkey)
Pathway
rro01521
EGFR tyrosine kinase inhibitor resistance
rro01522
Endocrine resistance
rro01524
Platinum drug resistance
rro04012
ErbB signaling pathway
rro04014
Ras signaling pathway
rro04022
cGMP-PKG signaling pathway
rro04024
cAMP signaling pathway
rro04062
Chemokine signaling pathway
rro04140
Autophagy - animal
rro04151
PI3K-Akt signaling pathway
rro04210
Apoptosis
rro04370
VEGF signaling pathway
rro04510
Focal adhesion
rro04722
Neurotrophin signaling pathway
rro04910
Insulin signaling pathway
rro04919
Thyroid hormone signaling pathway
rro05010
Alzheimer disease
rro05014
Amyotrophic lateral sclerosis
rro05020
Prion disease
rro05022
Pathways of neurodegeneration - multiple diseases
rro05145
Toxoplasmosis
rro05152
Tuberculosis
rro05160
Hepatitis C
rro05161
Hepatitis B
rro05162
Measles
rro05165
Human papillomavirus infection
rro05168
Herpes simplex virus 1 infection
rro05170
Human immunodeficiency virus 1 infection
rro05200
Pathways in cancer
rro05203
Viral carcinogenesis
rro05207
Chemical carcinogenesis - receptor activation
rro05208
Chemical carcinogenesis - reactive oxygen species
rro05210
Colorectal cancer
rro05211
Renal cell carcinoma
rro05212
Pancreatic cancer
rro05213
Endometrial cancer
rro05215
Prostate cancer
rro05218
Melanoma
rro05220
Chronic myeloid leukemia
rro05221
Acute myeloid leukemia
rro05223
Non-small cell lung cancer
rro05225
Hepatocellular carcinoma
rro05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
rro00001
]
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
104673141 (BAD)
04014 Ras signaling pathway
104673141 (BAD)
04370 VEGF signaling pathway
104673141 (BAD)
04024 cAMP signaling pathway
104673141 (BAD)
04022 cGMP-PKG signaling pathway
104673141 (BAD)
04151 PI3K-Akt signaling pathway
104673141 (BAD)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
104673141 (BAD)
09143 Cell growth and death
04210 Apoptosis
104673141 (BAD)
09144 Cellular community - eukaryotes
04510 Focal adhesion
104673141 (BAD)
09150 Organismal Systems
09151 Immune system
04062 Chemokine signaling pathway
104673141 (BAD)
09152 Endocrine system
04910 Insulin signaling pathway
104673141 (BAD)
04919 Thyroid hormone signaling pathway
104673141 (BAD)
09156 Nervous system
04722 Neurotrophin signaling pathway
104673141 (BAD)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
104673141 (BAD)
05207 Chemical carcinogenesis - receptor activation
104673141 (BAD)
05208 Chemical carcinogenesis - reactive oxygen species
104673141 (BAD)
05203 Viral carcinogenesis
104673141 (BAD)
09162 Cancer: specific types
05210 Colorectal cancer
104673141 (BAD)
05212 Pancreatic cancer
104673141 (BAD)
05225 Hepatocellular carcinoma
104673141 (BAD)
05221 Acute myeloid leukemia
104673141 (BAD)
05220 Chronic myeloid leukemia
104673141 (BAD)
05218 Melanoma
104673141 (BAD)
05211 Renal cell carcinoma
104673141 (BAD)
05215 Prostate cancer
104673141 (BAD)
05213 Endometrial cancer
104673141 (BAD)
05223 Non-small cell lung cancer
104673141 (BAD)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
104673141 (BAD)
05161 Hepatitis B
104673141 (BAD)
05160 Hepatitis C
104673141 (BAD)
05162 Measles
104673141 (BAD)
05168 Herpes simplex virus 1 infection
104673141 (BAD)
05165 Human papillomavirus infection
104673141 (BAD)
09171 Infectious disease: bacterial
05152 Tuberculosis
104673141 (BAD)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
104673141 (BAD)
09164 Neurodegenerative disease
05010 Alzheimer disease
104673141 (BAD)
05014 Amyotrophic lateral sclerosis
104673141 (BAD)
05020 Prion disease
104673141 (BAD)
05022 Pathways of neurodegeneration - multiple diseases
104673141 (BAD)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
104673141 (BAD)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
104673141 (BAD)
01524 Platinum drug resistance
104673141 (BAD)
01522 Endocrine resistance
104673141 (BAD)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Bcl-2_BAD
Bclx_interact
Motif
Other DBs
NCBI-GeneID:
104673141
NCBI-ProteinID:
XP_010375394
UniProt:
A0A2K6PUL3
LinkDB
All DBs
Position
15:complement(11488544..11505615)
Genome browser
AA seq
167 aa
AA seq
DB search
MFQIPEFEPSEQEDSSSAERGLGPSPAGDRPSDSGKHHRQAPGLLWDASHQQEQPTSSSH
HGGAGAVETRSRHSSYPAGTEEDEGMEEEPSPFRGRSRSAPPNLWAAQRYGRELRRMSDE
FVDSFKGLPRPKSAGTATQMRQSSSWTRVFQSWWDRNLGRGSSAPSQ
NT seq
504 nt
NT seq
+upstream
nt +downstream
nt
atgttccagatcccagagtttgagcctagtgagcaggaagactccagctctgcagagagg
ggcctgggccccagcccggcaggggacaggccctcagactccggcaagcatcatcgccag
gccccaggcctcctgtgggacgccagtcaccagcaggagcagccaaccagcagcagccat
catggaggcgctggggctgtggagacccggagtcgccacagctcctaccccgcggggacg
gaggaggacgaagggatggaggaggagcccagcccctttcggggccgctcgcgctccgcg
ccccctaacctctgggcagcacagcgatatggccgcgagctccggaggatgagtgacgag
tttgtggactcctttaagggacttcctcgcccgaagagcgcgggtacagcgacgcagatg
cggcaaagctccagctggacgcgagtcttccagtcctggtgggatcggaacttgggcagg
ggaagctccgccccctcccagtga
DBGET
integrated database retrieval system